𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hypothalamic cathepsin D: Assay and isoenzyme composition

✍ Scribed by T. N. Akopyan; N. A. Barchudaryan; L. V. Karabashyan; A. A. Arutunyan; A. Lajtha; A. A. Galoyan


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
310 KB
Volume
4
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


I NTROD UCTl ON

Cathepsin D, one of the main intr-acellular proteinases. plays an important role in the breakdown of proteins in normal cells [ l , 21 and also in thc pathologic processes of tissue breakdown [3,4]. Although the successful purification of this enzyme has been reported from different sources [5-9] , data concerning the isoenzyme composition of this enzyme are lacking.

Previously, we reported thc purification and some properties of acid proteinase from bovine hypothalamus, including its action o n somatostatin and substance P [ l o ] . This enzyme was identified by us as cathepsin D (EC 3.4.2.3). During purification of calhepsin D from hypothalamus we observed multiple peaks of enzyme activity. This observation was extended t o study the isoenzyme composition of cathepsin D in hypothalamus. and powerful method. A difficulty of this method is that fractions from focusing columns contain ampholines and sucrose, which interfere with those methods of measuring proteinase activity that utilize amino group and tyrosinc-detecting reagents.

for endopeptidase assay and the use of this method for determination of acid proteinases of bovine hypothalamus separated by an isoelectric focusing column.

For resolution of enzymes having similar activities, isoelectric focusing is a suitable In this communication, we report the development of a simple and sensitive method Address reprint requests to T.


πŸ“œ SIMILAR VOLUMES


An improved cathepsin-D substrate and as
✍ Nirankar Agarwal; Daniel H. Rich πŸ“‚ Article πŸ“… 1983 πŸ› Elsevier Science 🌐 English βš– 544 KB

Ten analogs of the peptide A-Phe(NO+Phe-Val-Leu-B were synthesized and tested as sub strates for cathepsin D and pepsin. The best substrate found for cathepsin D, Phe-Ala-Ala-Phe(NO,)-Phe-Val-Leu-OM4P (& = 2.9 s-l; K,,, = 7.1 PM), has the largest k&K,,, value (408 mM-' s-r) reported to date for thi

Clinical significance of cathepsin D ass
✍ Yukashi Itoh; Shunzo Kobayashi; Hirotaka Iwase; Hiroko Yamashita; Tatsuya Kuzush πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 474 KB

## Abstract Cathepsin D was assayed in 74 primary breast cancer specimens by enzyme immunoassay (EIA) and immunohistochemical assay (ICA). Of the 74 specimens, 38 (51.4%) were scored positive by ICA, and 25 (33.8%) were scored positive by EIA. The coincidence rate between ICA and EIA was 71.6% (53/

Comparison of cathepsin d determinations
✍ Raymond M. Shaheen; Slobodan Miseljic; David L. Doering; Dr. James L. Wittliff πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 566 KB

Overexpression of cathepsin 0 in several types of carcinoma in women appears to be associated with a poor clinical course. In this prospective investigation, cathepsin D levels in 170 specimens of normal and neoplastic human tissues were determined simultaneously by enzyme immunoassay (EIA) and immu

Inhibition of cruzipain visualized in a
✍ Morten Meldal; Ib Svendsen; Luiz Juliano; Maria A. Juliano; Elaine Del Nery; Jul πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 2 views

A PEGA-resin was derivatized with a 3 : 1 mixture of hydroxymethyl benzoic acid and Fmoc-Lys(Boc)-OH and the fluorogenic substrate Ac-Y(NO 2 )KLRFSKQK(Abz)Β±PEGA was assembled on the lysine using the active ester approach. Following esterification of the hydroxymethyl benzoic acid with Fmoc-Val-OH a

Abnormal expression of four novel molecu
✍ Han, Sehwan; Yun, Ik-Jin; Noh, Dong-Young; Choe, Kuk-Jin; Song, Sang-Yong; Chi, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 248 KB πŸ‘ 2 views

## Background: In view of the cumulative results to date, p53, nm23, erbb-2, and cathepsin d are the most promising investigational prognostic factors in breast cancer. ## Objectives: The clinical utility of these molecular markers to predict recurrence was evaluated. ## Methods: Archival patho